Loss of protein expression of hMLH1 and hMSH2 with double primary carcinomas of the stomach and colorectum

Oncology Reports

Volumn 16, Issue 1, 2006, Pages 41-47

  Yamamoto, Manabu ^a,d   Taguchi, Kenichi ^b   Baba, Hideo ^c   Endo, Kazuya ^b   Kohnoe, Shunji ^b   Okamura, Takeshi ^b   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

Author keywords

Colorectal carcinoma; Familial; Gastric carcinoma; Microsatellite instability; MLH; MSH

Indexed keywords

CARRIER PROTEIN; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN MSH2;

AGED; ARTICLE; BIOSYNTHESIS; CARCINOMA; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; STOMACH TUMOR; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA; CARRIER PROTEINS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM METASTASIS; NUCLEAR PROTEINS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 33750738882     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.1.41     Document Type: Article

References (39)

1. Tsukuma H, Fujimoto I, Hanai A, Hiyama T, Kitagawa T and Kinoshita N: Incidence of second primary cancers in Osaka resistants, Japan, with special reference to cumulative and relative risks. Jpn J Cancer Res 85: 339-345, 1994. (Pubitemid 24129612)
2. Santos MC, Gardner B and Feldman J: Analysis of multiple primary cancers in a single institution. J Surg Oncol 55: 95-99, 1994. (Pubitemid 24083530)
3. Okamoto N, Morio S, Inoue R and Akiyama K: The risk of a second primary cancer occurring in five-year survivors of an initial cancer. Jpn J Clin Oncol 17: 205-213, 1987.
4. Sasaki A, Furusawa M, Tomoda H, Seo Y, Ohno S, Morita M, Matsukima A and Kakeji Y: Evaluation of multiple cancer on patients with early gastric cancer. Jpn J Gastroenterol Surg 27: 1747-1752, 1994.
5. Liu B, Parsons RE, Hamilton SR, Petersen GM, Lynch HT, Watson P, Markowitz S, Willson JKV, Green J, de la Chapelle A, Kinzler KW and Vogelstein B: hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 54: 4590-4594, 1994. (Pubitemid 24276477)
6. Kolodner RD, Hall NR, Lipford J, Kane MF, Morrison PT, Finan PJ, Burn J, Chapman P, Earabino C, Merchant E and Bishop DT: Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal cancer kindred for mlh1 mutations. Cancer Res 55: 242-248, 1995.
7. Vasen HFA, Mecklin JP, Khan PM and Lynch HT: The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34: 424-425, 1991.
8. Watson P and Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71: 677-685, 1993. (Pubitemid 23051366)
9. Aarnio M, Mecklin JP, Aaltonen L, Nyström-Lahti M and Järvinen HJ: Life-time risk of different cancers in hereditary nonpolyposis colorectal cancer (HNPCC) syndrom. Int J Cancer 64: 430-433, 1995. (Pubitemid 26048907)
10. Vasen HFA, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagaengast FM, Meijers-Heijboer H, Bertario L, Varesco L, Bisgaard ML, Mohr J, Fodde R and Khan PM: Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110: 1020-1027, 1996. (Pubitemid 26113739)
11. Vasen HFA, Sanders EA, Taal BG, Nagengast FM, Griffioen G, Menko FH, Kleibeuker JH, Houwing-Duistermaat JJ and Khan PM: The risk of brain tumours in hereditary nonpolyposis colorectal cancer (HNPCC). Int J Cancer 65: 422-425, 1996. (Pubitemid 26083245)
12. Sijmons RH, Kiemeney LA, Witjes JA and Vasen HF: Urinary tract cancer and hereditary nonopolyposis colorectal cancer: risks and screening options. J Urol 160: 466-470, 1998. (Pubitemid 29476699)
13. TNM classification of malignant tumors (UICC). 5th edition, Wiley-Liss, New York, 1997.
14. Warren S and Gates O: Multiple primary malignant tumors. Am J Cancer 16: 1358-1414, 1932.
15. Moertel CG, Bargen JA and Soule EH: Multiple gastric cancers: Review of the literature and study of 42 cases. Gastroenterology 32: 1095-1103, 1957.
16. Maehara Y, Oda S and Sugimachi K: The instability within: problems in current analyses of microsatellite instability. Mutat Res 461: 249-263, 2001.
17. Salahshor S, Koelbel K, Rubio C and Lindblom A: Microsatellite instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer. Lab Invest 81: 535-541, 2001. (Pubitemid 32298799)
18. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM and Kolodner R: Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human cell lines. Cancer Res 57: 808-811, 1997. (Pubitemid 27097998)
19. Salvesen HB, MacDonald N, Ryan A, Iversen OE, Jacobs IJ, Akslen LA and Das S: Methylation of hMLH1 in a population-based series of endometrial carcinomas. Clin Cancer Res 6: 3607-3613, 2000.
20. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN and Srivastava S: A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257, 1998. (Pubitemid 28521189)
21. Maruyama H, Hasuike Y, Furukawa J, Naoi M, Takata N, Yayoi E, Okamura J and Okamoto S: Multiple colorectal carcinomas and colorectal carcinoma associated with extracolonic malignancy. Surg Today 22: 99-104, 1992.
22. Varty PP, Delrio P and Boulos PB: Survival in colorectal carcinoma associated with previous extracolonic cancer. Ann R Coll Surg Engl 76: 180-184, 1994. (Pubitemid 24145049)
23. Lundegardh G, Hansson LE, Nyren O, Adami HO and Krusemo UB: The risk of gastrointestinal and other primary malignant disease following gastric cancer. Acta Oncol 30: 1-6, 1991.
24. Tomoda H, Taketomi A, Baba H, Kohnoe S, Seo Y and Saito T: Multiple primary colorectal and gastric carcinoma in Japan. Oncol Rep 5: 147-149, 1998. (Pubitemid 28039836)
25. Ward R, Meagher A, Tomlinson I, O'Conner T, Norrie M, Wu R and Hawkins N: Miscrosatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 48: 821-829, 2001. (Pubitemid 32476985)
26. Baek MJ, Kang H, Kim SE, Park JH, Lee JS, Paik YK and Kim H: Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability. Br J Cancer 85: 1147-1152, 2001. (Pubitemid 33052313)
27. Percesepe A, Borghi F, Menigatti M, Losi L, Di Gregorio C, Foroni M, Rossi G, Pedroni M, Sala E, Vaccina F, Roncucci L, Benatti P, Viel A, Genuardi M, Marra G, Kristo P, Peltomaki P and Ponz de Leon M: Molecular screening for herediary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol 19: 3944-3950, 2001. (Pubitemid 32912021)
28. Laiho P, Launonen V, Lahermo P, Esteller M, Herman JG, Guo M, Mecklin JP, Järvinen H, Sistonen P, Kim KM, Shibata D, Houlston RS and Aaltonen LA: Low-level microsatellite instability in most colorectal carcinomas. Cancer Res 62: 1166-1170, 2002. (Pubitemid 34160304)
29. Perrin J, Gouvernet J, Parriaux D, Noguchi T, Giovannini MH, Giovannini M, Delpero JR, Birnbarm D and Monges G: MSH2 and MLH1 immunodetection and the prognosis of colon cancer. Int J Oncol 19: 891-895, 2001.
30. Hemminki A, Mecklin JP, Järvinen H, Aaltonen LA and Joensuu H: Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 119: 921-928, 2000.
31. Percesepe A, Benatti P, Roncucci L, Sassatelli R, Fante R, Ganazzi D, Bellacosa A, Genuardi M, Neri G, Viel A and Ponz de Leon M: Survival analysis in families affected by hereditary nonpolyposis colorectal cancer. Int J Cancer 71: 373-376, 1997. (Pubitemid 27224300)
32. Curran B, Lenehan K, Mulcahy H, Tighe O, Bennett MA, Kay EW, O'Donoghue DP, Leader M and Croke DT: Replication error phenotype, clinicopathological variables, and patients outcome in Dukes B stage II (T3,N0,M0) colorectal cancer. Gut 46: 200-204, 2000. (Pubitemid 30305845)
33. Caduff RF, Johnston CM, Svoboda-Newman SM, Poy EL, Merajver SD and Frank TS: Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. Am J Pathol 148: 1671-1678, 1996. (Pubitemid 26135906)
34. Paulson TG, Wright FA, Parker BA, Russack V and Wahl GM: Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. Cancer Res 56: 4021-4026, 1996. (Pubitemid 26284754)
35. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M and Gallinger S: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349: 247-257, 2003. (Pubitemid 36859476)
36. Morita M, Kuwano H, Baba H, Taketomi A, Kohnoe S, Tomoda H, Araki K, Saeki H, Kitamura K and Sugimachi K: Multifocal occurrence of gastric carcinoma in patients with a family history of gastric carcinoma. Cancer 83: 1307-1311, 1998. (Pubitemid 28460080)
37. Nakashima H, Honda M, Inoue H, Shibuta K, Arinaga S, Era S, Ueo H, Mori M and Akiyoshi T: Microsatellite instability in multiple gastric cancers. Int J Cancer 64: 239-242, 1995.
38. dos Santos NR, Seruca R, Constancia M, Seixas M and Sobrinho-Simoes M: Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis. Gastroenterology 110: 38-44, 1996. (Pubitemid 26021602)
39. Miyoshi E, Haruma K, Hiyama T, Tanaka S, Yoshihara M, Shimamoto F and Chayama K: Microsatellite instability is a genetic marker for the development of multiple gastric cancers. Int J Cancer 95: 350-353, 2001. (Pubitemid 33015103)